147 related articles for article (PubMed ID: 35285867)
1. Referral Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing.
van den Bersselaar LR; Hellblom A; Gashi M; Kamsteeg EJ; Voermans NC; Jungbluth H; de Puydt J; Heytens L; Riazi S; Snoeck MMJ
Anesthesiology; 2022 Jun; 136(6):940-953. PubMed ID: 35285867
[TBL] [Abstract][Full Text] [Related]
2. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review.
Kraeva N; Sapa A; Dowling JJ; Riazi S
Can J Anaesth; 2017 Jul; 64(7):736-743. PubMed ID: 28326467
[TBL] [Abstract][Full Text] [Related]
3. RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor Dysfunction.
Kruijt N; den Bersselaar LV; Snoeck M; Kramers K; Riazi S; Bongers C; Treves S; Jungbluth H; Voermans N
Curr Pharm Des; 2022; 28(1):2-14. PubMed ID: 34348614
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular symptoms in patients with
van den Bersselaar LR; Jungbluth H; Kruijt N; Kamsteeg EJ; Fernandez-Garcia MA; Treves S; Riazi S; Malagon I; van Eijk LT; van Alfen N; van Engelen BGM; Scheffer GJ; Snoeck MMJ; Voermans NC
Brain Commun; 2022; 4(6):fcac292. PubMed ID: 36751502
[TBL] [Abstract][Full Text] [Related]
5. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
[TBL] [Abstract][Full Text] [Related]
6. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis.
Dlamini N; Voermans NC; Lillis S; Stewart K; Kamsteeg EJ; Drost G; Quinlivan R; Snoeck M; Norwood F; Radunovic A; Straub V; Roberts M; Vrancken AF; van der Pol WL; de Coo RI; Manzur AY; Yau S; Abbs S; King A; Lammens M; Hopkins PM; Mohammed S; Treves S; Muntoni F; Wraige E; Davis MR; van Engelen B; Jungbluth H
Neuromuscul Disord; 2013 Jul; 23(7):540-8. PubMed ID: 23628358
[TBL] [Abstract][Full Text] [Related]
7. Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.
Riazi S; Kraeva N; Hopkins PM
Anesthesiology; 2018 Jan; 128(1):168-180. PubMed ID: 28902675
[TBL] [Abstract][Full Text] [Related]
8. Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness.
Fiszer D; Shaw MA; Fisher NA; Carr IM; Gupta PK; Watkins EJ; Roiz de Sa D; Kim JH; Hopkins PM
Anesthesiology; 2015 May; 122(5):1033-46. PubMed ID: 25658027
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH).
Riazi S; Bersselaar LRVD; Islander G; Heytens L; Snoeck MMJ; Bjorksten A; Gillies R; Dranitsaris G; Hellblom A; Treves S; Kunst G; Voermans NC; Jungbluth H
Neuromuscul Disord; 2022 Aug; 32(8):628-634. PubMed ID: 35738978
[TBL] [Abstract][Full Text] [Related]
10. RYR1 mutations as a cause of ophthalmoplegia, facial weakness, and malignant hyperthermia.
Shaaban S; Ramos-Platt L; Gilles FH; Chan WM; Andrews C; De Girolami U; Demer J; Engle EC
JAMA Ophthalmol; 2013 Dec; 131(12):1532-40. PubMed ID: 24091937
[TBL] [Abstract][Full Text] [Related]
11. A Single-Center Retrospective Review of Patients with Suspected Malignant Hyperthermia Susceptibility.
Edwards C; Dooley FC; Gonzalez S; Austin TM; Gravenstein N
Cureus; 2023 Sep; 15(9):e44661. PubMed ID: 37799222
[TBL] [Abstract][Full Text] [Related]
12. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N
Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196
[TBL] [Abstract][Full Text] [Related]
13. Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations.
Carsana A
ScientificWorldJournal; 2013; 2013():531465. PubMed ID: 23476141
[TBL] [Abstract][Full Text] [Related]
14. The histopathological spectrum of malignant hyperthermia and rhabdomyolysis due to RYR1 mutations.
Knuiman GJ; Küsters B; Eshuis L; Snoeck M; Lammens M; Heytens L; De Ridder W; Baets J; Scalco RS; Quinlivan R; Holton J; Bodi I; Wraige E; Radunovic A; von Landenberg C; Reimann J; Kamsteeg EJ; Sewry C; Jungbluth H; Voermans NC
J Neurol; 2019 Apr; 266(4):876-887. PubMed ID: 30788618
[TBL] [Abstract][Full Text] [Related]
15. Muscle Ultrasound Abnormalities in Individuals with RYR1-Related Malignant Hyperthermia Susceptibility.
van den Bersselaar LR; van Alfen N; Kruijt N; Kamsteeg EJ; Fernandez-Garcia MA; Treves S; Riazi S; Yang CY; Malagon I; van Eijk LT; van Engelen BGM; Scheffer GJ; Jungbluth H; Snoeck MMJ; Voermans NC
J Neuromuscul Dis; 2023; 10(4):541-554. PubMed ID: 37154182
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia.
White R; Schiemann AH; Burling SM; Bjorksten A; Bulger T; Gillies R; Hopkins PM; Kamsteeg EJ; Machon RG; Massey S; Miller D; Perry M; Snoeck MMJ; Stephens J; Street N; van den Bersselaar LR; Stowell KM
Br J Anaesth; 2022 Dec; 129(6):879-888. PubMed ID: 36208971
[TBL] [Abstract][Full Text] [Related]
17. The neuromuscular and multisystem features of RYR1-related malignant hyperthermia and rhabdomyolysis: A study protocol.
van den Bersselaar LR; Kruijt N; Scheffer GJ; van Eijk L; Malagon I; Buckens S; Custers JA; Helder L; Greco A; Joosten LA; van Engelen BG; van Alfen N; Riazi S; Treves S; Jungbluth H; Snoeck MM; Voermans NC
Medicine (Baltimore); 2021 Aug; 100(33):e26999. PubMed ID: 34414986
[TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS Scientific Conference.
Riazi S; Kraeva N; Muldoon SM; Dowling J; Ho C; Petre MA; Parness J; Dirksen RT; Rosenberg H
Can J Anaesth; 2014 Nov; 61(11):1040-9. PubMed ID: 25189431
[TBL] [Abstract][Full Text] [Related]
19. RYR1-related rhabdomyolysis: A common but probably underdiagnosed manifestation of skeletal muscle ryanodine receptor dysfunction.
Voermans NC; Snoeck M; Jungbluth H
Rev Neurol (Paris); 2016 Oct; 172(10):546-558. PubMed ID: 27663056
[TBL] [Abstract][Full Text] [Related]
20. Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance.
Hoppe K; Jurkat-Rott K; Kranepuhl S; Wearing S; Heiderich S; Merlak S; Klingler W
Sci Rep; 2021 Feb; 11(1):3445. PubMed ID: 33564012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
